HNF Collaborates with Rarebase on a Drug Discovery Platform to Develop Treatments for Charcot-Marie-Tooth (CMT)

The Hereditary Neuropathy Foundation (HNF), in partnership with Rarebase, is leading the charge in the first-ever research initiative to tackle multiple types of CMT in one project, with a primary goal to test candidate drugs in patient-derived cellular models, specifically; iPSC-derived neurons.